LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

LLY

713.66

-0.21%↓

JNJ

153.02

+0.33%↑

ABBV

183.38

+0.57%↑

NVO

67.22

-1.34%↓

UNH

295.3

-0.39%↓

Search

West Pharmaceutical Services Inc

Chiusa

SettoreSettore sanitario

205.31 -1.53

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

202.14

Massimo

208.27

Metriche Chiave

By Trading Economics

Entrata

-40M

90M

Vendite

-51M

698M

P/E

Media del settore

34.154

54.533

EPS

1.45

Rendimento da dividendi

0.39

Margine di Profitto

12.865

Dipendenti

10,600

EBITDA

-54M

151M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+41.49% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.39%

2.41%

Utili prossimi

24 lug 2025

Prossima data del Dividendo

6 ago 2025

Prossima data del' Ex Dividendo

30 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

257M

16B

Apertura precedente

206.84

Chiusura precedente

205.31

Notizie sul Sentiment di mercato

By Acuity

50%

50%

174 / 382 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Strong Bullish Evidence

West Pharmaceutical Services Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

22 mag 2025, 23:48 UTC

Azioni calde

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22 mag 2025, 23:07 UTC

Notizie principali

Fortescue Energy CEO to Resign in Executive Overhaul

22 mag 2025, 23:03 UTC

I principali Market Mover

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22 mag 2025, 23:59 UTC

Discorsi di Mercato

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22 mag 2025, 23:45 UTC

Discorsi di Mercato

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22 mag 2025, 23:45 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

22 mag 2025, 23:23 UTC

Discorsi di Mercato

Global Energy Roundup: Market Talk

22 mag 2025, 23:23 UTC

Discorsi di Mercato

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22 mag 2025, 23:12 UTC

Notizie principali

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

22 mag 2025, 21:54 UTC

Notizie principali

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

22 mag 2025, 20:50 UTC

Discorsi di Mercato

Auto & Transport Roundup: Market Talk

22 mag 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

22 mag 2025, 20:46 UTC

Acquisizioni, Fusioni, Takeovers

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22 mag 2025, 20:39 UTC

Utili

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22 mag 2025, 20:36 UTC

Notizie principali

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22 mag 2025, 20:36 UTC

Notizie principali
Utili

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22 mag 2025, 20:32 UTC

Notizie principali
Utili

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mag 2025, 20:27 UTC

Notizie principali

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22 mag 2025, 20:20 UTC

Notizie principali

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mag 2025, 20:17 UTC

Notizie principali

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22 mag 2025, 20:16 UTC

Utili

Intchains Group 1Q Rev $18.2M >ICG

22 mag 2025, 20:15 UTC

Notizie principali

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mag 2025, 20:08 UTC

Notizie principali
Utili

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mag 2025, 20:05 UTC

Notizie principali

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22 mag 2025, 20:04 UTC

Utili

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22 mag 2025, 20:04 UTC

Utili

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22 mag 2025, 20:01 UTC

Utili

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22 mag 2025, 20:01 UTC

Utili

Workday 1Q Net $68M >WDAY

22 mag 2025, 20:01 UTC

Utili

Workday 1Q EPS 25c >WDAY

22 mag 2025, 20:01 UTC

Utili

Workday 1Q Adj EPS $2.23 >WDAY

Confronto tra pari

Modifica del prezzo

West Pharmaceutical Services Inc Previsione

Obiettivo di Prezzo

By TipRanks

41.49% in crescita

Previsioni per 12 mesi

Media 295 USD  41.49%

Alto 370 USD

Basso 245 USD

Basato su 7 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per West Pharmaceutical Services Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

7 ratings

7

Acquista

0

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

213.26 / 219.27Supporto e resistenza

A breve termine

Strong Bullish Evidence

A termine intermedio

Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

174 / 382 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo West Pharmaceutical Services Inc

West Pharmaceutical Services, Inc. is a global manufacturer in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. Its products include various primary packaging, containment solutions, reconstitution, and transfer systems, and drug delivery systems, as well as contract manufacturing, analytical lab services, and integrated solutions. The Company’s segments include Proprietary Products and Contract-Manufactured Products. Proprietary Products reportable segment offers proprietary packaging, containment, and drug delivery products, along with analytical lab services and other integrated services. Contract-Manufactured Products segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.